J&J Faces Shareholder Action Over Drug Woes
Johnson & Johnson has been hit with a putative shareholder class action alleging a failure to disclose manufacturing violations that led to several recalls of popular children's medications and government scrutiny,...To view the full article, register now.
Already a subscriber? Click here to view full article